Cures 2.0 Would Mandate More FDA Centers of Excellence But Oncology-Style Funding Gaps Could Doom Plan

The two new intercenter institutes, one to focus on a common group of diseases and the other on rare diseases, appear to be unfunded mandates, which could hinder the agency’s ability to get them up and running.

empty wallet
Congress may require FDA establish new Centers of Excellence without any corresponding new funding. • Source: Alamy

The US Food and Drug Administration would need to establish two new intercenter institutes or “Centers of Excellence” if Congress clears the new Cures 2.0 legislation. But without any new funding to do it, the plan could frustrate the agency, which has run into budgetary challenges with its first such intercenter institute the Oncology Center of Excellence.

The draft Cures 2.0 legislation requires the two centers to be established within a year of the bill’s enactment or...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership